Critical role of CXC chemokines in endotoxemic liver injury in mice.
Hartmut
H
Jaeschke
Mary Lynn
ML
Bajt
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D017209:Apoptosis / Q000276:immunology*; D054360:Chemokine CXCL1; D054426:Chemokine CXCL2; D018925:Chemokines / Q000037:antagonists & inhibitors / Q000276:immunology; D019743:Chemokines, CXC / Q000037:antagonists & inhibitors / Q000276:immunology*; D002634:Chemotaxis, Leukocyte / Q000276:immunology; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000276:immunology; D004195:Disease Models, Animal; D019446:Endotoxemia / Q000139:chemically induced / Q000503:physiopathology* / Q000628:therapy; D004731:Endotoxins; D005688:Galactosamine; D017093:Liver Failure / Q000139:chemically induced / Q000503:physiopathology* / Q000628:therapy; D051379:Mice; D015203:Reproducibility of Results; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000906:Antibodies; D054360:Chemokine CXCL1; D054426:Chemokine CXCL2; D018925:Chemokines; D019743:Chemokines, CXC; C475895:Cxcl1 protein, mouse; C404915:Cxcl2 protein, mouse; D016207:Cytokines; D004731:Endotoxins; D014409:Tumor Necrosis Factor-alpha; C074302:keratinocyte-derived chemokines; D005688:Galactosamine